Roche Diagnostics GmbH (manufacturing of unpackaged products, primary packaging, quality control testing, quality control testing at stability)

The drug is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease), as well as primary progressive multiple sclerosis.

Dosage form: concentrate for infusion solution

ATC: L04AG08